Learn more

SCHERING AG

Overview
  • Total Patents
    27,250
About

SCHERING AG has a total of 27,250 patent applications. Its first patent ever was published in 1927. It filed its patents most often in Germany, United States and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and basic materials chemistry are JIANGSU NHWALUOKANG PHARMACEUTICAL RES AND DEVELOPMENT CO LTD, SICOR INC and KLAR ULRICH.

Patent filings in countries

World map showing SCHERING AGs patent filings in countries
# Country Total Patents
#1 Germany 3,622
#2 United States 1,817
#3 EPO (European Patent Office) 1,394
#4 Canada 1,166
#5 Australia 1,144
#6 France 992
#7 Denmark 973
#8 WIPO (World Intellectual Property Organization) 958
#9 Switzerland 912
#10 United Kingdom 877
#11 South Africa 799
#12 Japan 789
#13 Israel 729
#14 Norway 706
#15 Spain 653
#16 Austria 647
#17 Hungary 619
#18 Ireland 612
#19 Finland 508
#20 Netherlands 454
#21 Sweden 412
#22 Brazil 406
#23 China 364
#24 Belgium 358
#25 Poland 299
#26 New Zealand 295
#27 Czechoslovakia 288
#28 German Democratic Republic 283
#29 Italy 274
#30 Argentina 272
#31 USSR (Union of Socialist Soviet Republics) 241
#32 Portugal 232
#33 Greece 211
#34 Yugoslavia (Serbia and Montenegro) 203
#35 Mexico 201
#36 Bulgaria 186
#37 Taiwan 166
#38 Czechia 165
#39 Romania 158
#40 Slovakia 154
#41 Uruguay 145
#42 Republic of Korea 143
#43 Peru 136
#44 Philippines 114
#45 Egypt 98
#46 Ukraine 91
#47 Hong Kong 88
#48 Turkey 85
#49 Estonia 73
#50 Luxembourg 65
#51 EAPO (Eurasian Patent Organization) 58
#52 Russian Federation 54
#53 Croatia 50
#54 Ecuador 47
#55 Dominican Republic 46
#56 India 42
#57 Panama 42
#58 Serbia 31
#59 Costa Rica 30
#60 Iceland 28
#61 Morocco 27
#62 El Salvador 27
#63 Malaysia 24
#64 Zimbabwe 24
#65 African Regional Industrial Property Organization 17
#66 Cyprus 16
#67 Chile 14
#68 Slovenia 13
#69 Kenya 10
#70 African Intellectual Property Organization 10
#71 Latvia 8
#72 Saudi Arabia 8
#73 Indonesia 7
#74 Cuba 6
#75 Singapore 6
#76 Guatemala 5
#77 Lithuania 5
#78 Montenegro 5
#79 Jordan 3
#80 Algeria 2
#81 Honduras 2
#82 Malawi 2
#83 Zambia 2
#84 Colombia 1
#85 Monaco 1

Patent filings per year

Chart showing SCHERING AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wiechert Rudolf 811
#2 Skuballa Werner 744
#3 Platzek Johannes 652
#4 Arndt Friedrich 632
#5 Elger Walter 622
#6 Laurent Henry 555
#7 Huth Andreas 493
#8 Raduechel Bernd 437
#9 Wiechert R 421
#10 Arndt F 369

Latest patents

Publication Filing date Title
TW200745025A Amide inhibitors of leukotriene A4 hydrolase
US2007203096A1 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
WO2007065534A1 Method for recovering iopromide suitable for pharmaceutical purposes from mother liquors
BRPI0604318A d-homo-17-chlor-16 (17) -ene steroids
WO2007073792A1 Process for preparing 4,4- diphenylcyclohexanol
WO2007039318A2 Neuropeptide y analogs
ZA200607349B Flat system for using in the oral cavity
TW200716098A Acyltryptophanols
US2006292074A1 Tomoregulin antibodies and uses thereof
US2007142464A1 Nonsteroidal progesterone receptor modulators
US2006281744A1 Inhibitors of soluble adenylate cyclase
WO2006128735A1 Anti-inflammatory preparations and their intrathecal use in the therapy of inflammatory diseases of the central nervous system
TW200724679A Treatment of disease using an improved regulated expression system
TW200711651A Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate
DE102006021267A1 Glucocorticoid receptor ligand transactivation and transrepression activity characterizing method for primary immune cell, involves verifying regulation of expression of gene for determining transrepression and transactivation of ligand
WO2006114324A1 Compounds comprising cyclized somatostatin receptor binding peptides
WO2006114323A2 Orthogonally protected bifunctional amino acid
WO2006113247A1 Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci
AU2006201095A1 Identification and characterisation of function blocking anti-ED-B fibronectin antibodies
PT103452A Polypeptides specifically connected to the fibronectin ed-b domain with special sequences